Clinical Trial Update: A Study of the Safety and Activity of Liposomal Irinotecan in Combination With the 5-FU and Oxaliplatin in the Preoperative Treatment of Pancreatic Adenocarcinoma [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating liposomal irinotecan in combination with 5-FU and oxaliplatin as preoperative therapy for pancreatic adenocarcinoma, with results pos…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Adenocarcinoma

Drugs mentioned

• 5-FU (5-fluorouracil)
• Eloxatin (oxaliplatin)
• Onivyde (irinotecan hydrochloride liposome injection)

Snippet

Sponsor: University of Florida | Conditions: Pancreatic Adenocarcinoma | Phase 2 | Status: ACTIVE_NOT_RECRUITING | Results posted: 2024-09-23